With a number of COVID-19 vaccine trials now focusing on paediatric populations across various age groups, specific factors need to be considered.

The following article explores issues such as the consent process for paediatric involvment, the robust immune responses of children, and monitoring for signs of exacerbated immune responses and multisystem inflammatory syndrome in children.

Whilst severe COVID-19 disease in children is rare, the immunisation of children against COVID-19 disease will play an important role in achieving herd immunity.

To read more, please read the article below:
nature: COVID vaccines and kids: five questions as trials begin